DK0788480T3 - Krystallisering af levobupivacain og analoger deraf - Google Patents

Krystallisering af levobupivacain og analoger deraf

Info

Publication number
DK0788480T3
DK0788480T3 DK95934738T DK95934738T DK0788480T3 DK 0788480 T3 DK0788480 T3 DK 0788480T3 DK 95934738 T DK95934738 T DK 95934738T DK 95934738 T DK95934738 T DK 95934738T DK 0788480 T3 DK0788480 T3 DK 0788480T3
Authority
DK
Denmark
Prior art keywords
pct
levobupivacaine
analogues
crystallization
sec
Prior art date
Application number
DK95934738T
Other languages
Danish (da)
English (en)
Inventor
Marianne Langston
Benjamin Mark Skead
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421476A external-priority patent/GB9421476D0/en
Priority claimed from GBGB9504926.8A external-priority patent/GB9504926D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of DK0788480T3 publication Critical patent/DK0788480T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK95934738T 1994-10-25 1995-10-23 Krystallisering af levobupivacain og analoger deraf DK0788480T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421476A GB9421476D0 (en) 1994-10-25 1994-10-25 Process and salt
GBGB9504926.8A GB9504926D0 (en) 1995-03-10 1995-03-10 Crystallisation
PCT/GB1995/002513 WO1996012699A1 (fr) 1994-10-25 1995-10-23 Cristallisation de la levobupicavaine et des analogues de celle-ci

Publications (1)

Publication Number Publication Date
DK0788480T3 true DK0788480T3 (da) 2003-09-29

Family

ID=26305863

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95934738T DK0788480T3 (da) 1994-10-25 1995-10-23 Krystallisering af levobupivacain og analoger deraf

Country Status (16)

Country Link
US (1) US5994548A (fr)
EP (1) EP0788480B1 (fr)
JP (1) JP3911545B2 (fr)
AT (1) ATE245629T1 (fr)
AU (1) AU698637B2 (fr)
CA (1) CA2200355C (fr)
DE (1) DE69531356T2 (fr)
DK (1) DK0788480T3 (fr)
ES (1) ES2202375T3 (fr)
FI (1) FI117438B (fr)
HU (1) HU227420B1 (fr)
MX (1) MX9703024A (fr)
NO (1) NO309266B1 (fr)
PL (1) PL183210B1 (fr)
PT (1) PT788480E (fr)
WO (1) WO1996012699A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP1575569B1 (fr) 2002-12-13 2010-09-29 Durect Corporation Forme d'administration orale de medicaments comprenant un vehicule liquide de haute viscosite
US7094812B2 (en) * 2003-04-24 2006-08-22 Xerox Corporations Colorant compositions
US6790267B1 (en) * 2003-04-24 2004-09-14 Xerox Corporation Colorant compositions
SI2767292T1 (sl) 2004-09-17 2017-01-31 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
WO2007123405A1 (fr) * 2006-04-25 2007-11-01 Dishman Pharmaceuticals And Chemicals Ltd. chlorhydrate de ropivacaine ANHYDRE et PRÉPARATION de celui-ci
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
US8415401B2 (en) 2007-12-06 2013-04-09 Durect Corporation Oral pharmaceutical dosage forms
DK2234974T3 (da) * 2008-01-15 2012-06-25 Pharmathen Sa Fremgangsmåde til fremstilling af (S)-1-alkyl-2',6'-pipecoloxylidid-forbindelse
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN103073484B (zh) * 2013-01-28 2014-10-22 山东诚创医药技术开发有限公司 一种甲哌卡因及其光学对映体的制备方法
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
BR112019013192A2 (pt) * 2016-12-26 2019-12-10 Cellix Bio Private Ltd composto e composição farmacêutica
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (fr) * 1967-05-18 1971-12-27 Sterling Drug Inc
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide

Also Published As

Publication number Publication date
PL183210B1 (pl) 2002-06-28
JPH10507464A (ja) 1998-07-21
CA2200355C (fr) 2007-03-06
AU698637B2 (en) 1998-11-05
NO309266B1 (no) 2001-01-08
EP0788480B1 (fr) 2003-07-23
FI117438B (fi) 2006-10-13
WO1996012699A1 (fr) 1996-05-02
PL319829A1 (en) 1997-09-01
FI971711A (fi) 1997-04-22
US5994548A (en) 1999-11-30
NO971903D0 (no) 1997-04-24
NO971903L (no) 1997-04-24
DE69531356T2 (de) 2004-05-27
MX9703024A (es) 1997-10-31
EP0788480A1 (fr) 1997-08-13
ATE245629T1 (de) 2003-08-15
PT788480E (pt) 2003-12-31
HUT77631A (hu) 1998-06-29
CA2200355A1 (fr) 1996-05-02
FI971711A0 (fi) 1997-04-22
HU227420B1 (en) 2011-05-30
JP3911545B2 (ja) 2007-05-09
ES2202375T3 (es) 2004-04-01
DE69531356D1 (de) 2003-08-28
AU3704895A (en) 1996-05-15

Similar Documents

Publication Publication Date Title
DK0788480T3 (da) Krystallisering af levobupivacain og analoger deraf
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DE69406522T2 (de) Verfahren zur Herstellung von alkalilöslichen Emulsionscopolymeren
DE69109401D1 (de) Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
DK0822816T3 (da) Dermatologisk præparat til behandling af actiniske keratoser
DE59405969D1 (de) Verfahren zur Herstellung von Polyasparaginsäure
NO20013128D0 (no) Sementblanding og fremgangsmåte dertil
DE59204902D1 (de) Verfahren zur Herstellung von Diphenylaminen
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
DE59105224D1 (de) Verfahren zur Herstellung von N-substituierten Pyrrolidonen.
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DK0586589T3 (da) Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
DK0620607T3 (da) Fremgangsmåde til elektrolytisk behandling af brugte batterier
ES2116089T3 (es) Elemento de bastidor.
ES2162078T3 (es) Compuestos terapeuticos.
DE69210933T2 (de) Verfahren zur Herstellung von Alpha, Omega-Dihydroxyperfluoroalkylethylmethylpolysiloxanen
DE69200603T2 (de) Verfahren zur Behandlung von verbrauchten Nickelenthaltenden Ätzlösungen.
DE58902228D1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
DE69103913D1 (de) Verfahren zur Herstellung von Dodekandicarbonsäure.
NO881414D0 (no) Fremgangsmaate for behandling av spillvann og annet urent vann.
ATE131936T1 (de) Vorrichtung zur befestigung von zwei oder mehreren seismischen energiequellen an relativ fixierte positionen
DE68913394T2 (de) Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen.
ATE84780T1 (de) Neue di(meth)acrylate, verfahren zu deren herstellung und deren verwendung.
DE59200254D1 (de) Verfahren zur Herstellung von N-(Hydroxyalkyl)-carbamidsäure- alkylestern.
DE59106854D1 (de) Verfahren zur Herstellung von N-(2-Chlor-pyridin-5-yl-methyl)-ethylendiamin.